Your browser doesn't support javascript.
loading
Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and older.
Beeslaar, Johannes; Mather, Susan; Absalon, Judith; Eiden, Joseph J; York, Laura J; Crowther, Graham; Maansson, Roger; Maguire, Jason D; Peyrani, Paula; Perez, John L.
Afiliação
  • Beeslaar J; Pfizer Vaccine Clinical Research and Development, Horizon Building, Honey Lane, Hurley, SL6 6RJ, UK. Electronic address: johannes.beeslaar@pfizer.com.
  • Mather S; Pfizer Worldwide Research and Development, 500 Arcola Rd, Collegeville, PA, USA. Electronic address: susan.mather@pfizer.com.
  • Absalon J; Pfizer Vaccine Clinical Research and Development, 401 North Middletown Rd, Pearl River, NY, USA. Electronic address: judith.absalon@pfizer.com.
  • Eiden JJ; Pfizer Vaccine Clinical Research and Development, 401 North Middletown Rd, Pearl River, NY, USA. Electronic address: eidenj@icloud.com.
  • York LJ; Pfizer Vaccine Medical Development, Scientific & Clinical Affairs, 500 Arcola Rd, Collegeville, PA, USA. Electronic address: laurayork@outlook.com.
  • Crowther G; Pfizer Vaccine Clinical Research and Development, Horizon Building, Honey Lane, Hurley, SL6 6RJ, UK. Electronic address: graham.crowther@pfizer.com.
  • Maansson R; Pfizer Vaccine Clinical Research and Development, 500 Arcola Rd, Collegeville, PA, USA. Electronic address: roger.maansson@pfizer.com.
  • Maguire JD; Pfizer Vaccine Clinical Research and Development, 401 North Middletown Rd, Pearl River, NY, USA. Electronic address: jason.maguire@pfizer.com.
  • Peyrani P; Pfizer Vaccine Clinical Research and Development, 500 Arcola Rd, Collegeville, PA, USA. Electronic address: paula.peyrani@pfizer.com.
  • Perez JL; Pfizer Vaccine Clinical Research and Development, 500 Arcola Rd, Collegeville, PA, USA. Electronic address: john.perez@pfizer.com.
Vaccine ; 40(12): 1872-1878, 2022 03 15.
Article em En | MEDLINE | ID: mdl-35164991

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Meningocócicas / Neisseria meningitidis Sorogrupo B / Infecções Meningocócicas Tipo de estudo: Clinical_trials Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Meningocócicas / Neisseria meningitidis Sorogrupo B / Infecções Meningocócicas Tipo de estudo: Clinical_trials Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article